Stock TELA TELA BIO, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News TELA Bio, Inc.

Equities

TELA

US8723811084

Real-time Estimate Cboe BZX
Other stock markets
 13:32:33 2024-05-02 EDT 		5-day change 1st Jan Change
4.665 USD +0.76% Intraday chart for TELA Bio, Inc. +6.26% -29.53%
04-15 TELA Bio, Inc. Announces U.S. Commercial Launch of Robotic-Compatible OviTex IHR CI
03-22 Piper Sandler Adjusts Price Target on TELA Bio to $12 From $15, Maintains Overweight Rating MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Morgans rates ARX as Add
AQ
TELA Bio to Announce First Quarter 2024 Financial Results
GL
TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex IHR, Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures
AQ
TELA Bio Announces U.S. Commercial Launch of Robotic-Compatible OviTex® IHR – Addressing the Need for a More Natural Repair in Inguinal Hernia Procedures
GL
TELA Bio, Inc. Announces U.S. Commercial Launch of Robotic-Compatible OviTex IHR
CI
TELA Bio Welcomes Acclaimed Surgeon as Vice President of Medical Affairs and Surgeon Strategy
GL
Piper Sandler Adjusts Price Target on TELA Bio to $12 From $15, Maintains Overweight Rating
MT
Transcript : TELA Bio, Inc., Q4 2023 Earnings Call, Mar 21, 2024
Earnings Flash (TELA) TELA BIO Reports Q4 Revenue $17M, vs. Street Est of $16.4M
MT
TELA Bio, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
CI
TELA Bio Achieves Record Fourth Quarter and Full Year 2023 Revenues and Reports Complete Financial Results
GL
TELA Bio, Inc. Provides Revenue Guidance for the Full Year 2024
CI
TELA Bio Announces U.S. Commercial Launch of LIQUIFIX™ – the Only FDA-Approved Liquid Adhesive for Internal Use in Hernia Surgery
GL
TELA Bio, Inc. Announces U.S. Commercial Launch of LIQUIFIX
CI
MiMedx Group to Buy Distribution Rights for TELA Bio's Wound Care Product
MT
MIMEDX Expands Portfolio with Fibrillar Collagen Wound Dressing
AQ
TELA Bio Announces Sale of Distribution Rights for Wound Care Product to MIMEDX
GL
MiMedx Group, Inc. Enters into an Agreement with Tela Bio, Inc. to Obtain Exclusive Rights to Its Manufacturing and Supply Agreement
CI
TELA Bio to Announce Fourth Quarter and Full Year 2023 Financial Results
GL
TELA Bio to Announce Fourth Quarter and Full Year 2023 Financial Results
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TELA Stock
  4. News TELA Bio, Inc.